The Cannabinergic System as a Target for Anti-inflammatory Therapies

Authors: Lu, Dai; Kiran Vemuri, V.; Duclos, Richard I.; Jr.; Makriyannis, Alexandros

Source: Current Topics in Medicinal Chemistry, Volume 6, Number 13, July 2006 , pp. 1401-1426(26)

Publisher: Bentham Science Publishers

Buy & download fulltext article:


Price: $63.10 plus tax (Refund Policy)


Habitual cannabis use has been shown to affect the human immune system, and recent advances in endocannabinoid research provide a basis for understanding these immunomodulatory effects. Cell-based experiments or in vivo animal testing suggest that regulation of the endocannabinoid circuitry can impact almost every major function associated with the immune system. These studies were assisted by the development of numerous novel molecules that exert their biological effects through the endocannabinoid system. Several of these compounds were tested for their effects on immune function, and the results suggest therapeutic opportunities for a variety of inflammatory diseases such as multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, atherosclerosis, allergic asthma, and autoimmune diabetes through modulation of the endocannabinoid system.

Keywords: Cannabinoid; anti-inflammation; endocannabinoid system; immune modulation; inflammatory pain

Document Type: Research Article

Affiliations: Center for Drug Discovery,Northeastern University, 360 Huntington Avenue, 116 Mugar Hall, Boston,MA, 02115, USA.

Publication date: July 1, 2006

Related content



Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page